Ovarian cancer trials in Russia

2 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

  Where

  Omsk, Saint Petersburg

  Age

  18 years and over

  People

  250 worldwide

  Run by

  BioInvent International AB

  See details and how to joinNCT04752826 · EU 2023-509847-29-00
• Phase 2Taking people
  Intensification Treatment of Ovarian Cancer by PIPAC

  Where

  Balashikha

  Age

  18 years to 75 years

  People

  160

  Run by

  Moscow Regional Oncological Dispensary

  See details and how to joinNCT07514494